Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Other Non-Current Liabilities (2024 - 2025)

Connect Biopharma Holdings' Other Non-Current Liabilities history spans 2 years, with the latest figure at $118000.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $118000.0; the TTM value through Sep 2025 reached $118000.0, changed N/A, while the annual FY2024 figure was $632000.0, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $118000.0 at Connect Biopharma Holdings, down from $122000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $632000.0 in Q4 2024 and bottomed at $118000.0 in Q3 2025.